Walleye Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Buy |
8,437
+7,780
| +1,184% | +$608K | ﹤0.01% | 977 |
|
|
2025
Q1 | $47.6K | Sell |
657
-4,135
| -86% | -$300K | ﹤0.01% | 1633 |
|
|
2024
Q4 | $355K | Sell |
4,792
-95,386
| -95% | -$7.06M | ﹤0.01% | 1298 |
|
|
2024
Q3 | $6.61M | Buy |
100,178
+79,049
| +374% | +$5.22M | 0.01% | 363 |
|
|
2024
Q2 | $1.95M | Sell |
21,129
-66,563
| -76% | -$6.15M | ﹤0.01% | 827 |
|
|
2024
Q1 | $8.38M | Buy |
+87,692
| New | +$8.38M | 0.01% | 297 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2427 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2485 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2324 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2324 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2278 |
|
|
2022
Q3 | – | Sell |
-9,905
| Closed | -$942K | – | 2408 |
|
|
2022
Q2 | $942K | Buy |
+9,905
| New | +$942K | 0.03% | 664 |
|
|
2021
Q4 | – | Sell |
-6,166
| Closed | -$698 | – | 2100 |
|
|
2021
Q3 | $698 | Buy |
+6,166
| New | +$698 | 0.02% | 612 |
|
|
2019
Q3 | – | Sell |
-780
| Closed | -$48K | – | 655 |
|
|
2019
Q2 | $48K | Buy |
780
+330
| +73% | +$20.3K | 0.01% | 323 |
|
|
2019
Q1 | $29K | Buy |
+450
| New | +$29K | ﹤0.01% | 271 |
|